Cargando…

Prevention of SARS-CoV-2 transmission during a large, live, indoor gathering (SPRING): a non-inferiority, randomised, controlled trial

BACKGROUND: Mass indoor gatherings were banned in early 2020 to prevent the spread of SARS-CoV-2. We aimed to assess, under controlled conditions, whether infection rates among attendees at a large, indoor gathering event would be similar to those in non-attendees, given implementation of a comprehe...

Descripción completa

Detalles Bibliográficos
Autores principales: Delaugerre, Constance, Foissac, Frantz, Abdoul, Hendy, Masson, Guillaume, Choupeaux, Laure, Dufour, Eric, Gastli, Nabil, Delarue, Severine Mercier, Néré, Marie Laure, Minier, Marine, Gabassi, Audrey, Salmona, Maud, Seguineau, Malika, Schmitt, Sarah, Tonglet, Sébastien, Olivier, Alexis, Poyart, Claire, Le Goff, Jerôme, Lescure, Xavier, Kernéis, Solen, Tréluyer, Jean-Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8626094/
https://www.ncbi.nlm.nih.gov/pubmed/34843662
http://dx.doi.org/10.1016/S1473-3099(21)00673-3
_version_ 1784606580894859264
author Delaugerre, Constance
Foissac, Frantz
Abdoul, Hendy
Masson, Guillaume
Choupeaux, Laure
Dufour, Eric
Gastli, Nabil
Delarue, Severine Mercier
Néré, Marie Laure
Minier, Marine
Gabassi, Audrey
Salmona, Maud
Seguineau, Malika
Schmitt, Sarah
Tonglet, Sébastien
Olivier, Alexis
Poyart, Claire
Le Goff, Jerôme
Lescure, Xavier
Kernéis, Solen
Tréluyer, Jean-Marc
author_facet Delaugerre, Constance
Foissac, Frantz
Abdoul, Hendy
Masson, Guillaume
Choupeaux, Laure
Dufour, Eric
Gastli, Nabil
Delarue, Severine Mercier
Néré, Marie Laure
Minier, Marine
Gabassi, Audrey
Salmona, Maud
Seguineau, Malika
Schmitt, Sarah
Tonglet, Sébastien
Olivier, Alexis
Poyart, Claire
Le Goff, Jerôme
Lescure, Xavier
Kernéis, Solen
Tréluyer, Jean-Marc
author_sort Delaugerre, Constance
collection PubMed
description BACKGROUND: Mass indoor gatherings were banned in early 2020 to prevent the spread of SARS-CoV-2. We aimed to assess, under controlled conditions, whether infection rates among attendees at a large, indoor gathering event would be similar to those in non-attendees, given implementation of a comprehensive prevention strategy including antigen-screening within 3 days, medical mask wearing, and optimised ventilation. METHODS: The non-inferiority, prospective, open-label, randomised, controlled SPRING trial was done on attendees at a live indoor concert held in the Accor Arena on May 29, 2021 in Paris, France. Participants, aged 18–45 years, recruited via a dedicated website, had no comorbidities, COVID-19 symptoms, or recent case contact, and had had a negative rapid antigen diagnostic test within 3 days before the concert. Participants were randomly allocated in a 2:1 ratio to the experimental group (attendees) or to the control group (non-attendees). The allocation sequence was computer-generated by means of permuted blocks of sizes three, six, or nine, with no stratification. The primary outcome measure was the number of patients who were SARS-CoV-2-positive by RT-PCR test on self-collected saliva 7 days post-gathering in the per-protocol population (non-inferiority margin <0·35%). This trial is registered with ClinicalTrials.gov, NCT04872075. FINDINGS: Between May 11 and 25, 2021, 18 845 individuals registered on the dedicated website, and 10 953 were randomly selected for a pre-enrolment on-site visit. Among 6968 who kept the appointment and were screened, 6678 participants were randomly assigned (4451 were assigned to be attendees and 2227 to be non-attendees; median age 28 years; 59% women); 88% (3917) of attendees and 87% (1947) of non-attendees complied with follow-up requirements. The day 7 RT-PCR was positive for eight of the 3917 attendees (observed incidence, 0·20%; 95% CI 0·09–0·40) and three of the 1947 non-attendees (0·15%; 0·03–0·45; absolute difference, 95% CI −0·26% to 0·28%), findings that met the non-inferiority criterion for the primary endpoint. INTERPRETATION: Participation in a large, indoor, live gathering without physical distancing was not associated with increased SARS-CoV-2–transmission risk, provided a comprehensive preventive intervention was implemented. FUNDING: French Ministry of Health. TRANSLATION: For the French translation of the abstract see Supplementary Materials section.
format Online
Article
Text
id pubmed-8626094
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-86260942021-11-29 Prevention of SARS-CoV-2 transmission during a large, live, indoor gathering (SPRING): a non-inferiority, randomised, controlled trial Delaugerre, Constance Foissac, Frantz Abdoul, Hendy Masson, Guillaume Choupeaux, Laure Dufour, Eric Gastli, Nabil Delarue, Severine Mercier Néré, Marie Laure Minier, Marine Gabassi, Audrey Salmona, Maud Seguineau, Malika Schmitt, Sarah Tonglet, Sébastien Olivier, Alexis Poyart, Claire Le Goff, Jerôme Lescure, Xavier Kernéis, Solen Tréluyer, Jean-Marc Lancet Infect Dis Articles BACKGROUND: Mass indoor gatherings were banned in early 2020 to prevent the spread of SARS-CoV-2. We aimed to assess, under controlled conditions, whether infection rates among attendees at a large, indoor gathering event would be similar to those in non-attendees, given implementation of a comprehensive prevention strategy including antigen-screening within 3 days, medical mask wearing, and optimised ventilation. METHODS: The non-inferiority, prospective, open-label, randomised, controlled SPRING trial was done on attendees at a live indoor concert held in the Accor Arena on May 29, 2021 in Paris, France. Participants, aged 18–45 years, recruited via a dedicated website, had no comorbidities, COVID-19 symptoms, or recent case contact, and had had a negative rapid antigen diagnostic test within 3 days before the concert. Participants were randomly allocated in a 2:1 ratio to the experimental group (attendees) or to the control group (non-attendees). The allocation sequence was computer-generated by means of permuted blocks of sizes three, six, or nine, with no stratification. The primary outcome measure was the number of patients who were SARS-CoV-2-positive by RT-PCR test on self-collected saliva 7 days post-gathering in the per-protocol population (non-inferiority margin <0·35%). This trial is registered with ClinicalTrials.gov, NCT04872075. FINDINGS: Between May 11 and 25, 2021, 18 845 individuals registered on the dedicated website, and 10 953 were randomly selected for a pre-enrolment on-site visit. Among 6968 who kept the appointment and were screened, 6678 participants were randomly assigned (4451 were assigned to be attendees and 2227 to be non-attendees; median age 28 years; 59% women); 88% (3917) of attendees and 87% (1947) of non-attendees complied with follow-up requirements. The day 7 RT-PCR was positive for eight of the 3917 attendees (observed incidence, 0·20%; 95% CI 0·09–0·40) and three of the 1947 non-attendees (0·15%; 0·03–0·45; absolute difference, 95% CI −0·26% to 0·28%), findings that met the non-inferiority criterion for the primary endpoint. INTERPRETATION: Participation in a large, indoor, live gathering without physical distancing was not associated with increased SARS-CoV-2–transmission risk, provided a comprehensive preventive intervention was implemented. FUNDING: French Ministry of Health. TRANSLATION: For the French translation of the abstract see Supplementary Materials section. Elsevier Ltd. 2022-03 2021-11-26 /pmc/articles/PMC8626094/ /pubmed/34843662 http://dx.doi.org/10.1016/S1473-3099(21)00673-3 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Articles
Delaugerre, Constance
Foissac, Frantz
Abdoul, Hendy
Masson, Guillaume
Choupeaux, Laure
Dufour, Eric
Gastli, Nabil
Delarue, Severine Mercier
Néré, Marie Laure
Minier, Marine
Gabassi, Audrey
Salmona, Maud
Seguineau, Malika
Schmitt, Sarah
Tonglet, Sébastien
Olivier, Alexis
Poyart, Claire
Le Goff, Jerôme
Lescure, Xavier
Kernéis, Solen
Tréluyer, Jean-Marc
Prevention of SARS-CoV-2 transmission during a large, live, indoor gathering (SPRING): a non-inferiority, randomised, controlled trial
title Prevention of SARS-CoV-2 transmission during a large, live, indoor gathering (SPRING): a non-inferiority, randomised, controlled trial
title_full Prevention of SARS-CoV-2 transmission during a large, live, indoor gathering (SPRING): a non-inferiority, randomised, controlled trial
title_fullStr Prevention of SARS-CoV-2 transmission during a large, live, indoor gathering (SPRING): a non-inferiority, randomised, controlled trial
title_full_unstemmed Prevention of SARS-CoV-2 transmission during a large, live, indoor gathering (SPRING): a non-inferiority, randomised, controlled trial
title_short Prevention of SARS-CoV-2 transmission during a large, live, indoor gathering (SPRING): a non-inferiority, randomised, controlled trial
title_sort prevention of sars-cov-2 transmission during a large, live, indoor gathering (spring): a non-inferiority, randomised, controlled trial
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8626094/
https://www.ncbi.nlm.nih.gov/pubmed/34843662
http://dx.doi.org/10.1016/S1473-3099(21)00673-3
work_keys_str_mv AT delaugerreconstance preventionofsarscov2transmissionduringalargeliveindoorgatheringspringanoninferiorityrandomisedcontrolledtrial
AT foissacfrantz preventionofsarscov2transmissionduringalargeliveindoorgatheringspringanoninferiorityrandomisedcontrolledtrial
AT abdoulhendy preventionofsarscov2transmissionduringalargeliveindoorgatheringspringanoninferiorityrandomisedcontrolledtrial
AT massonguillaume preventionofsarscov2transmissionduringalargeliveindoorgatheringspringanoninferiorityrandomisedcontrolledtrial
AT choupeauxlaure preventionofsarscov2transmissionduringalargeliveindoorgatheringspringanoninferiorityrandomisedcontrolledtrial
AT dufoureric preventionofsarscov2transmissionduringalargeliveindoorgatheringspringanoninferiorityrandomisedcontrolledtrial
AT gastlinabil preventionofsarscov2transmissionduringalargeliveindoorgatheringspringanoninferiorityrandomisedcontrolledtrial
AT delarueseverinemercier preventionofsarscov2transmissionduringalargeliveindoorgatheringspringanoninferiorityrandomisedcontrolledtrial
AT neremarielaure preventionofsarscov2transmissionduringalargeliveindoorgatheringspringanoninferiorityrandomisedcontrolledtrial
AT miniermarine preventionofsarscov2transmissionduringalargeliveindoorgatheringspringanoninferiorityrandomisedcontrolledtrial
AT gabassiaudrey preventionofsarscov2transmissionduringalargeliveindoorgatheringspringanoninferiorityrandomisedcontrolledtrial
AT salmonamaud preventionofsarscov2transmissionduringalargeliveindoorgatheringspringanoninferiorityrandomisedcontrolledtrial
AT seguineaumalika preventionofsarscov2transmissionduringalargeliveindoorgatheringspringanoninferiorityrandomisedcontrolledtrial
AT schmittsarah preventionofsarscov2transmissionduringalargeliveindoorgatheringspringanoninferiorityrandomisedcontrolledtrial
AT tongletsebastien preventionofsarscov2transmissionduringalargeliveindoorgatheringspringanoninferiorityrandomisedcontrolledtrial
AT olivieralexis preventionofsarscov2transmissionduringalargeliveindoorgatheringspringanoninferiorityrandomisedcontrolledtrial
AT poyartclaire preventionofsarscov2transmissionduringalargeliveindoorgatheringspringanoninferiorityrandomisedcontrolledtrial
AT legoffjerome preventionofsarscov2transmissionduringalargeliveindoorgatheringspringanoninferiorityrandomisedcontrolledtrial
AT lescurexavier preventionofsarscov2transmissionduringalargeliveindoorgatheringspringanoninferiorityrandomisedcontrolledtrial
AT kerneissolen preventionofsarscov2transmissionduringalargeliveindoorgatheringspringanoninferiorityrandomisedcontrolledtrial
AT treluyerjeanmarc preventionofsarscov2transmissionduringalargeliveindoorgatheringspringanoninferiorityrandomisedcontrolledtrial
AT preventionofsarscov2transmissionduringalargeliveindoorgatheringspringanoninferiorityrandomisedcontrolledtrial